Gingival Tissue Inflammation Pathway

The gingival tissue inflammation pathway refers to the complex network of molecular and cellular events that occur in response to bacterial biofilm (dental plaque) accumulation on teeth, leading to gingivitis and potentially progressing to periodontitis. This pathway involves both innate and adaptive immune responses, with a variety of cytokines, chemokines, immune cells, and signaling molecules orchestrating the inflammatory process. It's initiated by bacterial biofilm, resulting in the activation of resident leukocytes, endothelial cells, and junctional epithelium. The pathway progression can lead to irreversible tissue destruction including bone loss due to chronic inflammation. Targeting key mediators such as TNFα has shown clinical benefit in reducing periodontal indices.

Varies depending on the specific drug and target within the pathway. Examples include TNFα inhibition.